Table 2.

Distribution of cancer cell cycle after EN treatment (%)

Phase	Group A	Group B	Group C	Group D
G0G1	67.0 ± 5.1	78.9 ± 8.5ac	69.2 ± 6.2b	80.5 ± 9.0ac
S	20.1 ± 1.8	11.8 ± 2.9ac	19.9 ± 3.0b	10.2 ± 2.1ac
G2+M	12.9 ± 3.2	9.2 ± 3.1	10.9 ± 2.5	9.4 ± 3.8
PI(S+G2+M)	33.0 ± 4.3	21.0 ± 5.0ac	30.8 ± 5.6b	20. 5 ± 2.8ac

^aP < 0.05, vs group A,

^bP < 0.05, vs group B,

^cP < 0.05, vs group C